SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John H. Farro who wrote (2930)6/19/1997 9:15:00 AM
From: Hank   of 4342
 
Robin,

My opinion about the rumors of which you speak is that you are right on the money. Any large drug firm wanting to pursue these compounds as drugs could easily do so by obtaining the raw herbs and isolating the compounds themselves UNLESS the methods to purify and characterize them were patented. If PRLN had the entire process locked up in patents, then drug firms would have to strike a deal with them before they could pursue these compounds. I was hoping this might be the case but I fear it is not. The only advanages that PRLN had if they had pursued the dietary supplement route was 1) being the first to market and 2) price. Now, that is gone. As for rousting Rhodes and bringing back Babish, I understand that this is very unlikely if not impossible. Also, you might be intersted to know that it was Campbell that filed a suit in Delaware to force PRLN to hold a stock holders meeting. Of course, this is officially rumor also since PRLN never admitted that such a suit was even filed in the first place.

Hank
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News